Archive

News round-up: M&G portfolio targeting 'Paris-alignment'; Mirova fund hits $1bn milestone; Royal London sets net-zero goal

M&G updates £1bn in customer assets to target Paris-alignment

M&G Catalyst impact strategy invests in vaccine developer

M&G was lead investor in a funding round worth $168 million in Vaccitech, which co-invented a Covid-19 vaccine with the University of Oxford.